Treasurer of the State of North Carolina
XLRN

Treasurer of the State of North Carolina’s Acceleron Pharma XLRN Stock Holding History

Treasurer of the State of North Carolina’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-18,999
Closed -$3.27M – 1044
2021
Q3 		$3.27M Buy
18,999
+639
+3% +$83.6K 0.02% 642
2021
Q2 		$2.3M Sell
18,360
-490
-3% -$61.8K 0.01% 768
2021
Q1 		$2.56M Sell
18,850
-50
-0.3% -$6.46K 0.02% 703
2020
Q4 		$2.42M Buy
18,900
+50
+0.3% +$5.86K 0.02% 692
2020
Q3 		$2.12M Buy
18,850
+1,990
+12% +$198K 0.02% 677
2020
Q2 		$1.61M Buy
+16,860
New +$1.63M 0.01% 751

Treasurer of the State of North Carolina's XLRN Position: Q4 2021 in Review

Treasurer of the State of North Carolina sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 18,999 shares — an estimated $3.27M sold.

Treasurer of the State of North Carolina first reported a position in XLRN in Q2 2020 and held it in 6 quarters. The position peaked at $3.27M in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

  • Treasurer of the State of North Carolina reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
  • Treasurer of the State of North Carolina sold 18,999 Acceleron Pharma shares in Q4 2021, an estimated $3.27M.
  • Treasurer of the State of North Carolina first reported a position in Acceleron Pharma in Q2 2020 and held it in 6 quarters.
  • Treasurer of the State of North Carolina's Acceleron Pharma position peaked at $3.27M in Q3 2021.
  • 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Treasurer of the State of North Carolina's 13F filing for Q4 2021, filed 14 Feb 2022.